Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Taiwanese (TAIEX) Clinical Research and Equipment Industry Analysis

UpdatedApr 21, 2025
DataAggregated Company Financials
Companies9
  • 7D2.8%
  • 3M-14.3%
  • 1Y-17.2%
  • YTDn/a

Over the last 7 days, the Clinical Research and Equipment industry has risen 2.9%, driven by gains from EirGenix of 4.1%. Meanwhile, DuoGenic StemCells actually underperformed within the industry, shrinking 6.6% in the last week. In contrast, the industry has lost 17% in the last 12 months. Looking forward, earnings are forecast to grow by 26% annually.

Industry Valuation and Performance

Has the Taiwanese Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 21 Apr 2025NT$31.6bNT$2.5b-NT$540,128,000.0024.3x-58.5x12.8x
Wed, 19 Mar 2025NT$36.9bNT$2.6b-NT$849,328,000.0029.4x-43.5x14.4x
Fri, 14 Feb 2025NT$37.1bNT$2.6b-NT$854,432,000.0023.2x-43.4x14.5x
Sun, 12 Jan 2025NT$36.5bNT$2.6b-NT$854,432,000.0023.1x-42.7x14.2x
Tue, 10 Dec 2024NT$41.1bNT$2.6b-NT$854,432,000.0023.7x-48.1x16x
Thu, 07 Nov 2024NT$42.6bNT$2.5b-NT$712,402,000.0024.2x-59.8x17x
Sat, 05 Oct 2024NT$41.6bNT$2.3b-NT$836,610,000.0022.3x-49.7x18.3x
Mon, 02 Sep 2024NT$41.6bNT$2.3b-NT$836,610,000.0022.2x-49.7x18.3x
Wed, 31 Jul 2024NT$42.4bNT$2.1b-NT$797,765,000.0032.2x-53.1x19.8x
Fri, 28 Jun 2024NT$43.1bNT$2.1b-NT$797,765,000.0034.4x-54x20.2x
Sun, 26 May 2024NT$39.8bNT$2.1b-NT$797,765,000.0032.1x-49.8x18.6x
Tue, 23 Apr 2024NT$38.2bNT$2.1b-NT$923,759,000.0030x-41.4x18.1x
Thu, 21 Mar 2024NT$39.9bNT$2.1b-NT$611,433,000.0032.2x-65.3x19.4x
Sat, 17 Feb 2024NT$44.3bNT$2.1b-NT$610,218,000.0032.9x-72.5x21.3x
Mon, 15 Jan 2024NT$44.9bNT$2.1b-NT$610,218,000.0033.3x-73.6x21.6x
Wed, 13 Dec 2023NT$49.0bNT$2.1b-NT$610,218,000.0033.1x-80.3x23.6x
Fri, 10 Nov 2023NT$48.8bNT$2.2b-NT$497,769,000.0031.7x-98x21.9x
Sun, 08 Oct 2023NT$48.3bNT$2.2b-NT$497,769,000.0031.4x-97.1x21.7x
Tue, 05 Sep 2023NT$43.6bNT$2.2b-NT$497,769,000.0031.7x-87.5x19.6x
Thu, 03 Aug 2023NT$47.1bNT$2.5b-NT$274,767,000.0043x-171.3x19.2x
Sat, 01 Jul 2023NT$50.2bNT$2.5b-NT$274,767,000.0044x-182.6x20.5x
Mon, 29 May 2023NT$50.0bNT$2.5b-NT$262,467,000.0043.4x-190.4x20.2x
Wed, 26 Apr 2023NT$46.4bNT$2.7b-NT$29,761,000.0023.1x-1557.7x17.4x
Fri, 24 Mar 2023NT$48.5bNT$2.6b-NT$28,959,000.0024.2x-1674x18.3x
Sun, 19 Feb 2023NT$51.0bNT$2.7bNT$85.3m19.7x598x19.1x
Tue, 17 Jan 2023NT$45.9bNT$2.7bNT$85.3m18.9x538x17.1x
Thu, 15 Dec 2022NT$52.1bNT$2.7bNT$139.5m18.8x373.4x19.5x
Sat, 12 Nov 2022NT$45.5bNT$3.0bNT$480.6m23.9x94.6x15.2x
Mon, 10 Oct 2022NT$46.8bNT$3.0bNT$482.8m24.6x97x15.6x
Wed, 07 Sep 2022NT$50.2bNT$3.0bNT$482.8m26.7x103.9x16.8x
Fri, 05 Aug 2022NT$39.0bNT$3.1bNT$325.1m37.6x119.9x12.7x
Sun, 03 Jul 2022NT$38.5bNT$3.1bNT$325.1m36.8x118.5x12.6x
Tue, 31 May 2022NT$30.4bNT$3.1bNT$325.1m36.3x93.5x9.9x
Thu, 28 Apr 2022NT$34.2bNT$3.2bNT$164.4m28.1x208.1x10.7x
Price to Earnings Ratio

208.1x


Total Market Cap: NT$34.2bTotal Earnings: NT$164.4mTotal Revenue: NT$3.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Clinical Research and Equipment Industry Price to Earnings3Y Average -61.7x202320242025
Current Industry PE
  • Investors are pessimistic on the Taiwanese Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 17.7x is higher than the industry's current PS ratio of 12.8x.
Past Earnings Growth
  • Total earnings for the Life Sciences Tools and Services industry have declined over the last three years, with the industry now making a loss overall.
  • Revenues have also declined 8.2% per year, which is driving profits down.

Industry Comparison

How does Taiwanese Clinical Research and Equipment compare with similar industries?

TW Market-0.33%
Healthcare3.56%
Life Sciences2.82%
Clinical Research and Equipment2.82%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
4133 Abnova (Taiwan)NT$26.359.1%
+NT$133.2m		-12.7%PE25.9x
6662 BioLASCO TaiwanNT$33.755.5%
+NT$44.8m		-5.2%PE19.6x
6661 Welgene BiotechLtdNT$19.504.6%
+NT$19.8m		-14.5%PE410.5x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

6939

NT$24.05

TFBS Bioscience

7D

-1.6%

1Y

-42.5%

4133

NT$26.35

Abnova (Taiwan)

7D

9.1%

1Y

-12.7%

6986

NT$75.80

HeXun Biosciences

7D

-3.2%

1Y

13.0%

6589

NT$61.00

EirGenix

7D

-1.6%

1Y

-21.2%

6662

NT$33.75

BioLASCO Taiwan

7D

5.5%

1Y

-5.2%

6891

NT$21.65

Locus Cell

7D

-1.1%

1Y

-25.5%

6661

NT$19.50

Welgene BiotechLtd

7D

4.6%

1Y

-14.5%

7607

NT$15.35

DuoGenic StemCells

7D

-5.2%

1Y

-52.0%